Sep 19, 2022 / 02:00PM GMT
Operator
Good morning, and welcome to the Trevi Therapeutics R&D Day. (Operator Instructions). As a reminder, this call is being recorded and a replay will be made available on the Trevi website following the conclusion of the event. I'd now like to turn the call over to Katie McManus, Communications Manager at Trevi Therapeutics. Please go ahead, Katie.
Katie McManus -
Good morning, and welcome to Trevi Therapeutics R&D Day. Various remarks that management makes during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in Risk Factors section of the company's most recent quarterly report on Form 10-Q for the quarter ended June 30, 2022, filed with the Securities and Exchange Commission and then subsequent filings with the Security and Exchange Commission
Trevi Therapeutics Inc R&D Day (Virtual) Transcript
Sep 19, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers